WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Prestige Consumer Healthcare earnings were $214.6M for the trailing 12 months ending Mar 31, 2025, with 2.6% growth year over year. The latest PBH earnings report on Mar 31, 2025 announced Q1 2025 earnings of $50.1M, down 17.9% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, PBH reported annual earnings of $214.6M, with 2.5% growth.

PBH past earnings growth

How has PBH's earnings growth performed historically?

Company
2.61%
Industry
18.68%
Market
30.48%
PBH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PBH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PBH earnings history

Current Revenue
$1.1B
Current Earnings
$214.6M
Current Profit Margin
18.9%
PBH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PBH Return on Equity

Current Company
12.2%
Current Industry
12.8%
Current Market
31.3%
PBH's Return on Equity (12.2%)... subscribe to Premium to read more.
High Return on Equity Performance

PBH undefined

Current Company
6.4%
Current Industry
6.9%
PBH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PBH announces earnings.

PBH undefined

Current Company
10.07%
Current Industry
14.3%
PBH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBH vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PBH$369.24M$214.61M+8.98%$4.32
PRGO$590.60M-$80.30MN/A-$0.58
BHC$3.05B$98.00M+100.00%$0.26
AMRX$536.01M$3.38M-38.52%$0.01
INDV$261.00M$128.00MN/A$1.00
View Top Pharmaceutical Stocks

Prestige Consumer Healthcare Earnings Reports & History FAQ

What were Prestige Consumer Healthcare's earnings last quarter?

On PBH's earnings call on Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q1 2025 earnings per share (EPS) of $1.01, up 1% year over year. Total PBH earnings for the quarter were $50.13 million. In the same quarter last year, Prestige Consumer Healthcare's earnings per share (EPS) was $1.00.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

Is Prestige Consumer Healthcare profitable or losing money?

As of the last Prestige Consumer Healthcare earnings report, Prestige Consumer Healthcare is currently profitable. Prestige Consumer Healthcare's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $214.61 million, a 2.52% increase year over year.

What was PBH's earnings growth in the past year?

As of Prestige Consumer Healthcare's earnings date in Invalid Date, Prestige Consumer Healthcare's earnings has grown 2.61% year over year. This is 16.07 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 18.68%. PBH earnings in the past year totalled $214.61 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.